Amgen (AMGN) Appoints Michael V. Drake to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Morgan Stanley on Amgen (AMGN): 'We believe the acquisition will be viewed as a modest positive'
August 4, 2022 10:03 AM EDTMorgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $253.00 price target on Amgen (NASDAQ: AMGN).
The analyst comments "We believe the acquisition will be viewed as a modest positive given investors are looking for mgt. to expand the pipeline and near-term revenues.... More
